SCM
TEVA icon

Seascape Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Seascape Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,450
Closed -$238K – 73
2020
Q1 		$238K Buy
+26,450
New +$271K 0.22% 57

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Seascape Capital Management's TEVA Position: Q2 2020 in Review

Seascape Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2020, closing a stake of 26,450 shares — an estimated $238K sold.

Seascape Capital Management first reported a position in TEVA in Q1 2020 and held it in 1 quarter. The position peaked at $238K in Q1 2020. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Seascape Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2020 after selling out during the quarter.
  • Seascape Capital Management sold 26,450 Teva Pharmaceutical Industries Limited shares in Q2 2020, an estimated $238K.
  • Seascape Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 1 quarter.
  • Seascape Capital Management's Teva Pharmaceutical Industries Limited position peaked at $238K in Q1 2020.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2020.

Based on Seascape Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.